Trials / Conditions / Refractory Bladder Urothelial Carcinoma
Refractory Bladder Urothelial Carcinoma
3 registered clinical trials studyying Refractory Bladder Urothelial Carcinoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers NCT07087860 | Mayo Clinic | Phase 2 |
| Terminated | Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib NCT05052372 | xCures | — |
| Active Not Recruiting | Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastat NCT04579224 | National Cancer Institute (NCI) | Phase 3 |